Innovation in Animal Health with Pharmaceutical Rigor
We develop cannabidiol-based therapies with clinical evidence, proven safety, and the highest standards of the pharmaceutical industry.
About Vettiva
Vettiva is Brazil’s first veterinary pharmaceutical company exclusively dedicated to the Research & Development of innovative cannabidiol (CBD)-based therapies.
With over 20 years of accumulated experience in developing solutions for human health, we apply the same scientific, regulatory, and industrial rigor to animal care.
Our focus is on technical excellence at every stage of the pharmaceutical process — from active ingredient certification to formulation design, from clinical trials to final product presentation.
We pursue advanced technologies that ensure safety, efficacy, and real therapeutic benefits for animal health, following the highest standards of the industry.
Vettiva was founded by Dr. Gabriela Cezar, a veterinarian, PhD, scientist, and entrepreneur.
CEO of Panarea Partners — a global M&A advisory boutique specialized in healthcare — Dr. Gabriela is known for leading strategic operations for companies such as Aché Farmacêutica, Biolab Sanus, Algenis SpA, AmoyDX, and the Instituto D’Or de Pesquisa e Ensino (IDOR), among others.
Her career includes serving as an executive at Pfizer, where she led the External Research & Development Innovation division for Latin America and South Africa. She is also the co-founder and former CSO of Stemina Biomarker Discovery, a U.S.-based biotechnology company. Dr. Gabriela was also a professor and researcher in the Department of Animal Sciences at the University of Wisconsin–Madison, one of the most respected institutions in the field.
Timeline
2026
Forecast for Registration of the 1st Veterinary Medicine based on Cannabidiol.
Clinical Studies on Efficacy and Safety and Preparation of the Submission Dossier to the therapeutic candidate for MAPA.
2023
2021
Creation of Vettiva
The new specialty pharma of veterinary medical cannabis in Brazil.
Beginning of the pharmacological development of the cannabidiol-based innovative therapeutic candidate.
2018
2017
Panarea Transactions
Panarea Partners has a rich track record of successful transactions.
Foundation of Panarea Partners
Panarea Partners, a boutique M&A Advisory company in healthcare and a pioneer in global operations for clients such as Aché Laboratórios Farmacêuticos and Biolab Sanus, among others, is a shareholder in Vettiva.
2016
Contact Us
Avenida Nove de Julho 4939, Suite 13
Itaim Bibi
CEP: 01407-200 São Paulo, SP
Science and everyday life cannot and should not be separated."
Rosalind Fanklin
(1920 – 1958)